rheumatoid arthritis. Seropositive rheumatoid arthritis
Conditions
Interventions
daily 3 tablets of 140 mg livergol® for 3 months.
Treatment - Drugs
daily 3 tablets of 140 mg livergol® for 3 months
Sponsors
Vice Chancellor for research of Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: having four of the seven criteria, of American College of Rheumatology for six weeks and Diagnosis by a Rheumatologist Exclusion criteria: Patients participating in the study will be free to withdraw from the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Interleukin 1. Timepoint: before and after advising the drug. Method of measurement: ELISA.;TNF-a. Timepoint: before and after advising the drug. Method of measurement: ELISA.;Neopterin. Timepoint: before and after advising the drug. Method of measurement: HPLC.;Malondialdehyde. Timepoint: before and after advising the drug. Method of measurement: HPLC.;Catalase. Timepoint: before and after advising the drug. Method of measurement: spectrophotometry system.;Paraoxonase. Timepoint: before and after advising the drug. Method of measurement: spectrophotometry system. | — |
Secondary
| Measure | Time frame |
|---|---|
| ESR. Timepoint: before and after the drug. Method of measurement: westregreen.;CRP. Timepoint: before and after the drug. Method of measurement: ELISA.;Mmp-2. Timepoint: before and after the drug. Method of measurement: ELISA and gelatin zymography.;Mmp-9. Timepoint: before and after the drug. Method of measurement: ELISA and gelatin zymography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Amir Kiani
Kermanshah University of Medical Sciences
Outcome results
None listed